Bernadette M D'Souza, MD

Midwest Clinical research Center, One ...Dayton, Ohio - 45408 Midwest Clinical Research CenterDayton, Ohio - 45417 (937-424-1050) |
- CLINICAL TRIALS 4
- CONDITIONS6
- INTERVENTIONS7
- SINCE2009

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
April 2009 - September 2011

Efficacy Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder
May 2010 - July 2011

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
March 2010 - December 2011

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
April 2009 - February 2012
Depression
Depressive Disorder
Depressive Disorder, Major
Attention Deficit Disorder with Hyperactivity
Hyperkinesis
Bipolar Disorder
Placebo
Lurasidone + (Lithium Or Divalproex)
Placebo + (Lithium Or Divalproex)
Agomelatine (Ago178c)
Opdc-34712 + Stimulant Therapy
Placebo + Stimulant Therapy
Lurasidone



